Prophylactic gabapentin during head and neck cancer therapy: a systematic review and meta-analysis
Authors:
Open Access
- 17 March 2023
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (4) , 1-9
Abstract
Purpose: This review was designed to compile the currently available evidence on the prophylactic use of gabapentin in the head and neck cancer patient population. Methods: A systematic search was conducted of PubMed, Web of Science, and Google Scholar to identify articles related to the use of prophylactic gabapentin in patients undergoing head and neck cancer therapy. Candidate studies were screened for inclusion and a subsequent bias assessment was conducted by multiple reviewers. Meta-analysis was conducted in cases in which the studies used compatible outcome measures. Results: Ten studies were identified that met the inclusion criteria and were assessed for bias. Among the four small studies that examined pain prevention, 2 were positive and 2 were inconclusive. Three of the four studies examiniRDng opioid use noted less need for opioids in the treatment arm. Meta-analysis of the pertinent studies showed no difference in feeding tube placement (RD = 0.64%, 95%CI: (− 25.8%, 27.1%), p = 0.962) but substantially less weight loss among those in the treatment arm (p = 0.047). Conclusion: Prophylactic gabapentin appears to be a promising treatment option for preventing pain, reducing opioids, and reducing weight loss in patients undergoing head and neck cancer therapy. However, the studies on the treatment to date are small and several have a substantial risk of bias.Keywords
Funding Information
- National Institutes of Health (K23GM134482, K23DE028010)
This publication has 18 references indexed in Scilit:
- A single‐institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancerCancer, 2019
- Rising incidence of late‐stage head and neck cancer in the United StatesCancer, 2019
- Early onset oral tongue squamous cell carcinoma: Associated factors and patient outcomesHead & Neck, 2019
- One-Year Swallowing Outcomes in Patients Treated with Prophylactic Gabapentin During Radiation-Based Treatment for Oropharyngeal CancerDysphagia, 2017
- Randomized trial of standard pain control with or without gabapentin for pain related to radiation-induced mucositis in head and neck cancerAuris Nasus Larynx, 2016
- Pain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendationsCritical Reviews in Oncology/Hematology, 2016
- Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of GabapentinDysphagia, 2016
- Effect of Gabapentin on Swallowing During and After Chemoradiation for Oropharyngeal Squamous Cell CancerDysphagia, 2014
- Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCThe Lancet Oncology, 2012
- Gabapentin in the treatment of neuropathic painPalliative Medicine, 2004